Equities

Ethema Health Corp

GRST:PKL

Ethema Health Corp

Actions
  • Price (USD)0.0004
  • Today's Change0.000 / -12.50%
  • Shares traded1.08m
  • 1 Year change0.00%
  • Beta2.2985
Data delayed at least 15 minutes, as of May 24 2024 19:21 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ethema Health Corporation, together with its subsidiaries, operates in the behavioral healthcare space specifically in the treatment of substance-use disorders. The Company offers rehabilitation services in West Palm Beach, Florida. By working with scientists, doctors and researchers, the Company strives to develop better assessment and treatment modalities for the industry. The Company focuses on developing programs and techniques for North America.

  • Revenue in USD (TTM)5.34m
  • Net income in USD1.13m
  • Incorporated1993
  • Employees65.00
  • Location
    Ethema Health Corp950 EVERNIA STREETWEST PALM BEACH 33401United StatesUSA
  • Phone+1 (561) 593-8365
  • Websitehttps://ethemahealth.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
North America Frac Sand Inc0.00-226.72k378.12k3.00---------0.0034-0.00340.00-0.0122------0.00---5,915.30-----------193.66---16.94-----100.00--142.25------
China Health Management Corp.483.00k-25.60m405.73k56.00------0.84-1,378.45-1,378.4525.37-41.350.04251.161.498,625.00-190.82---395.01---2,014.49---4,486.13--0.0203-1,353.25----37.69---363.55------
Newregen Inc-100.00bn-100.00bn1.12m-----------------0.0054----------38,397.79-------------------------52.00------
QHSLab Inc1.41m-468.37k1.17m4.00------0.8338-0.0499-0.04990.1496-0.03860.774415.9823.66352,250.00-25.74-51.17---197.3156.32---33.24-65.100.0637-1.041.27--13.34--52.98------
avVaa World Health Care Products Inc39.74k49.55k1.26m2.0043.33--25.3631.610.000030.000030.00002-0.00690.8149--9.63--101.602,695.88----95.9280.55124.696,316.05------0.00142.40-12.09159.21------
Ethema Health Corp5.34m1.13m1.31m65.001.25--0.89510.24420.00030.00030.0014-0.00170.5912--16.4482,230.4611.13-37.68--------18.83-94.87---0.61875.04--10.8765.34652.41--74.97--
Cano Health Inc2.96bn-981.97m1.46m2.70k------0.0005-288.02-288.02894.93-163.911.98--19.941,094,546.00-101.44---125.72-------51.32-----6.02----14.56---186.78------
Mitesco Inc0.00-10.91m1.60m3.00---------1.91-1.940.00-2.600.00----0.00-10,172.81-246.54-----------29,214.62---0.1207---------59.12------
IMD Companies Inc439.50k-330.55k1.64m3.00------3.74-0.0053-0.00530.0049-0.00210.430331.325.58146,500.00-32.36-41.61-43.47-58.1633.5249.68-75.21-89.491.05--1.48--26.65---47.11------
Modern Mobility Aids Inc0.00-1.59m2.01m-----------0.0177-0.01770.00-0.0040.00-------4,668.68---------------------------371.94------
CompuMed Inc1.78m-151.00k2.30m8.00--17.71--1.30-0.1337-0.13371.580.09972.3836.714.83---19.92-46.77-48.38-76.7850.4257.04-8.38-25.840.9493-2.930.7744---1.73-5.7164.41---18.75--
Data as of May 24 2024. Currency figures normalised to Ethema Health Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.